Azure Healthcare sells CellGuard business
Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise
Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises
Essential IR Insights Newsletter - Summer July-August 2023
Insight Weekly: Climate law faces hurdles; US borrowing surges; banks revise uninsured deposits
Azure Healthcare Ltd. sold its CellGuard business to a private entity for A$1 million in cash.
The divestment of CellGuard, which manufactures speech-based call systems for secured facilities, will help strengthen Azure's balance sheet as it increases focus on its core healthcare business.
As of Dec. 22, US$1 was equivalent to A$1.38.
